{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:17:01Z","timestamp":1783142221775,"version":"3.54.6"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2025NSCQ-GPX0664"],"award-info":[{"award-number":["CSTB2025NSCQ-GPX0664"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572785"],"award-info":[{"award-number":["82572785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20413"],"award-info":[{"award-number":["U23A20413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.phrs.2026.108225","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:10:20Z","timestamp":1777579820000},"page":"108225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lysosome-triggered nanotherapy packages osteoclast apoptotic bodies with pro-anabolic lipids to couple anti-resorption and bone formation"],"prefix":"10.1016","volume":"228","author":[{"given":"Peng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixiu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiulin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhuai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuquan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-6354","authenticated-orcid":false,"given":"Ce","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108225_bib1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2026.108225_bib2","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","article-title":"The pathophysiology and treatment of osteoporosis","volume":"37","author":"Drake","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.phrs.2026.108225_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/nano11113124","article-title":"Challenges and recent advances in enzyme-mediated wastewater remediation-a review","volume":"11","author":"Al-Maqdi","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.phrs.2026.108225_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697137.2021.1951206","article-title":"Osteoporosis and fractures in women: the burden of disease","volume":"25","author":"Lorentzon","year":"2022","journal-title":"Climacteric"},{"key":"10.1016\/j.phrs.2026.108225_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jama.2025.6003","article-title":"Osteoporosis: a review","volume":"334","author":"Morin","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2026.108225_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41438-019-0140-8","article-title":"Prunus genetics and applications after de novo genome sequencing: achievements and prospects","volume":"6","author":"Aranzana","year":"2019","journal-title":"Hortic. Res."},{"key":"10.1016\/j.phrs.2026.108225_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5312\/wjo.v7.i3.171","article-title":"Major osteoporotic fragility fractures: risk factor updates and societal impact","volume":"7","author":"Pisani","year":"2016","journal-title":"World J. Orthop."},{"key":"10.1016\/j.phrs.2026.108225_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1142\/S0192415X24500393","article-title":"The role of traditional chinese medicines in the treatment of osteoporosis","volume":"52","author":"Wang","year":"2024","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib9","doi-asserted-by":"crossref","first-page":"20383","DOI":"10.1021\/acs.jafc.4c02982","article-title":"Tetrahydroberberine prevents ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and promoting osteoclast apoptosis","volume":"72","author":"Wu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2026.108225_bib10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J. Clin. Pr."},{"key":"10.1016\/j.phrs.2026.108225_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115850","article-title":"Bisphosphonates impair the onset of bone formation at remodeling sites","volume":"145","author":"Jensen","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2026.108225_bib12","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s11999-011-1909-8","article-title":"The effect of antiresorptives on bone quality","volume":"469","author":"Recker","year":"2011","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.phrs.2026.108225_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.20945\/2359-3997000000566","article-title":"Anabolic therapy for osteoporosis: update on efficacy and safety","volume":"66","author":"Bandeira","year":"2022","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2026.108225_bib14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11914-020-00652-w","article-title":"Romosozumab: a review of efficacy, safety, and cardiovascular risk","volume":"19","author":"Fixen","year":"2021","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.phrs.2026.108225_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1365.035","article-title":"Bone remodeling","volume":"1092","author":"Hadjidakis","year":"2006","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.phrs.2026.108225_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108225_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108225_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","article-title":"Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases","volume":"56","author":"Takegahara","year":"2024","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.phrs.2026.108225_bib20","unstructured":"Henry J.P., Bordoni B. 2025. Histology, Osteoblasts. In StatPearls. Treasure Island (FL)."},{"key":"10.1016\/j.phrs.2026.108225_bib21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/jbmr.4410","article-title":"The diverse origin of bone-forming osteoblasts","volume":"36","author":"Mizoguchi","year":"2021","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.phrs.2026.108225_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.semcdb.2008.07.016","article-title":"Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption","volume":"19","author":"Sims","year":"2008","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2026.108225_bib23","first-page":"481","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims","year":"2014","journal-title":"Bone Rep."},{"key":"10.1016\/j.phrs.2026.108225_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-021119-034425","article-title":"Osteoclasts provide coupling signals to osteoblast lineage cells through multiple mechanisms","volume":"82","author":"Sims","year":"2020","journal-title":"Annu Rev. Physiol."},{"key":"10.1016\/j.phrs.2026.108225_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","article-title":"Osteoblast-osteoclast interactions","volume":"59","author":"Chen","year":"2018","journal-title":"Connect Tissue Res."},{"key":"10.1016\/j.phrs.2026.108225_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis","volume":"4","author":"Zhao","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2026.108225_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108225_bib28","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI91086","article-title":"Osteoclast-secreted SLIT3 coordinates bone resorption and formation","volume":"128","author":"Kim","year":"2018","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2026.108225_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12951-023-01969-1","article-title":"Apoptotic bodies: bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials","volume":"21","author":"Yu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2026.108225_bib30","article-title":"Positive and negative regulators of osteoclast apoptosis","volume":"11","author":"Soysa","year":"2019","journal-title":"Bone Rep."},{"key":"10.1016\/j.phrs.2026.108225_bib31","first-page":"108","article-title":"Osteoclast-derived apoptotic bodies accelerate the pathological progression of osteoarthritis via disturbing subchondral bone remodeling","volume":"51","author":"Ai","year":"2025","journal-title":"J. Orthop. Transl."},{"key":"10.1016\/j.phrs.2026.108225_bib32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1186\/s12967-024-05451-w","article-title":"Tailoring of apoptotic bodies for diagnostic and therapeutic applications:advances, challenges, and prospects","volume":"22","author":"Miao","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib33","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.7150\/thno.45170","article-title":"Osteoclast-derived apoptotic bodies show extended biological effects of parental cell in promoting bone defect healing","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2026.108225_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41413-020-00121-1","article-title":"Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling","volume":"9","author":"Ma","year":"2021","journal-title":"Bone Res."},{"key":"10.1016\/j.phrs.2026.108225_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41420-023-01434-w","article-title":"Reduced osteoclast-derived apoptotic bodies in bone marrow characterizes the pathological progression of osteoporosis","volume":"9","author":"Wu","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phrs.2026.108225_bib36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jconrel.2022.09.045","article-title":"Apoptotic bodies for advanced drug delivery and therapy","volume":"351","author":"Zhou","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2026.108225_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biomaterials.2015.02.007","article-title":"A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts","volume":"52","author":"Liu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.108225_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib39","first-page":"1","article-title":"Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis","volume":"58","author":"Wu","year":"2026","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.phrs.2026.108225_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/mi.10.3.5","article-title":"Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition","volume":"10","author":"Drake","year":"2010","journal-title":"Mol. Inter."},{"key":"10.1016\/j.phrs.2026.108225_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2026.108225_bib42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bone.2015.08.020","article-title":"The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants","volume":"81","author":"Tsoumpra","year":"2015","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.phrs.2026.108225_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner Res."},{"key":"10.1016\/j.phrs.2026.108225_bib44","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2026.108225_bib45","article-title":"Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials","volume":"13","author":"Lu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108225_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10010152","article-title":"Denosumab discontinuation and the rebound phenomenon: a narrative review","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib47","first-page":"173","article-title":"Anabolic treatment for osteoporosis: teriparatide","volume":"14","author":"Eastell","year":"2017","journal-title":"Clin. Cases Min. Bone Metab."},{"key":"10.1016\/j.phrs.2026.108225_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00774-024-01536-0","article-title":"Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis","volume":"43","author":"Ebina","year":"2025","journal-title":"J. Bone Min. Metab."},{"key":"10.1016\/j.phrs.2026.108225_bib49","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s12967-023-04563-z","article-title":"Romosozumab in osteoporosis: yesterday, today and tomorrow","volume":"21","author":"Wu","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X19877994","article-title":"Update on the safety and efficacy of teriparatide in the treatment of osteoporosis","volume":"11","author":"Minisola","year":"2019","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.phrs.2026.108225_bib51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11914-014-0237-9","article-title":"Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches","volume":"12","author":"Cosman","year":"2014","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.phrs.2026.108225_bib52","first-page":"62","article-title":"Optimizing sequential and combined anabolic and antiresorptive osteoporosis therapy","volume":"2","author":"Leder","year":"2018","journal-title":"JBMR"},{"key":"10.1016\/j.phrs.2026.108225_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105357","article-title":"The role of fatty acids in ceramide pathways and their influence on hypothalamic regulation of energy balance: a systematic review","volume":"22","author":"Reginato","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108225_bib54","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1017\/S0007114520003177","article-title":"The impact of EPA and DHA on ceramide lipotoxicity in the metabolic syndrome","volume":"125","author":"Walchuk","year":"2021","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.phrs.2026.108225_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jbior.2016.10.002","article-title":"Ceramidases, roles in sphingolipid metabolism and in health and disease","volume":"63","author":"Coant","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.phrs.2026.108225_bib56","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41467-018-03844-2","article-title":"Structural basis for the activation of acid ceramidase","volume":"9","author":"Gebai","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108225_bib57","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1194\/jlr.M022384","article-title":"Sphingosine mediates TNFalpha-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells","volume":"53","author":"Ullio","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2026.108225_bib58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/etm.2022.11160","article-title":"Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose","volume":"23","author":"Cifuentes-Mendiola","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao1193","article-title":"\u03c9-3 polyunsaturated fatty acids direct differentiation of the membrane phenotype in mesenchymal stem cells to potentiate osteogenesis","volume":"3","author":"Levental","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2026.108225_bib60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11914-016-0321-4","article-title":"Advances in controlled drug delivery for treatment of osteoporosis","volume":"14","author":"Asafo-Adjei","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.phrs.2026.108225_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1431566","article-title":"Lysosomal biogenesis and function in osteoclasts: a comprehensive review","volume":"12","author":"Jiang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2026.108225_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165685","article-title":"Osteoclast multinucleation: review of current literature","volume":"21","author":"Kodama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108225_bib63","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.devcel.2011.08.016","article-title":"Autophagy proteins regulate the secretory component of osteoclastic bone resorption","volume":"21","author":"DeSelm","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.phrs.2026.108225_bib64","doi-asserted-by":"crossref","first-page":"11240","DOI":"10.1074\/jbc.RA119.007625","article-title":"Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling","volume":"294","author":"Ma","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108225_bib65","article-title":"Osteoclast-derived apoptotic bodies inhibit naive CD8(+) T cell activation via Siglec15, promoting breast cancer secondary metastasis","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib66","article-title":"Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108225_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2016.15","article-title":"Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity","volume":"2","author":"Sun","year":"2016","journal-title":"Cell Discov."},{"key":"10.1016\/j.phrs.2026.108225_bib68","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/nm.3668","article-title":"PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108225_bib69","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.omtn.2021.01.031","article-title":"Osteoclast-derived small extracellular vesicles induce osteogenic differentiation via inhibiting ARHGAP1","volume":"23","author":"Liang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2026.108225_bib70","doi-asserted-by":"crossref","DOI":"10.34133\/research.0840","article-title":"Lysosome-iron-mitochondria axis in osteoclasts: iron as a central player","volume":"8","author":"Qin","year":"2025","journal-title":"Research"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:38:17Z","timestamp":1783139897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":70,"alternative-id":["S1043661826001404"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108225","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysosome-triggered nanotherapy packages osteoclast apoptotic bodies with pro-anabolic lipids to couple anti-resorption and bone formation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108225"}}